Research programme: muscarinic M4 receptor agonists - Banyu

Drug Profile

Research programme: muscarinic M4 receptor agonists - Banyu

Alternative Names: Muscarinic M4 receptor agonists research programme - Banyu

Latest Information Update: 05 Oct 2006

Price : $50

At a glance

  • Originator Banyu
  • Class
  • Mechanism of Action Muscarinic M4 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Pain

Most Recent Events

  • 04 Oct 2006 Discontinued - Preclinical for Pain in Japan (unspecified route)
  • 23 Apr 2001 Preclinical development for Pain in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top